Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$90.24 - $124.05 $365,832 - $502,898
-4,054 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$93.66 - $139.27 $124,755 - $185,507
-1,332 Reduced 24.73%
4,054 $503,000
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $124,380 - $165,395
-1,067 Reduced 16.53%
5,386 $710,000
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $672,068 - $958,883
-6,747 Reduced 51.11%
6,453 $855,000
Q3 2020

Oct 30, 2020

SELL
$72.92 - $102.01 $80,212 - $112,211
-1,100 Reduced 7.69%
13,200 $1.35 Million
Q2 2020

Aug 05, 2020

BUY
$55.75 - $92.75 $797,225 - $1.33 Million
14,300 New
14,300 $1.24 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.